ADVIA CENTAUR XP VB12 ASSAY N/A 10309970

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2017-03-16 for ADVIA CENTAUR XP VB12 ASSAY N/A 10309970 manufactured by Siemens Healthcare Diagnostics, Inc..

Event Text Entries

[70178705] A siemens customer service engineer (cse) was at the customer site for system inspection. The cse did not observe any instrument issues. The cause for the falsely elevated or imprecise advia centaur xp vb12 (vitamin b12) results when comparing the advia centaur xp systems, or elevated results compared to an alternate vb 12 test method is unknown. Siemens is investigating. The instructions for use (ifu) under the interpretation of results section states the following: "results of this assay should always be interpreted in conjunction with patient's medical history, clinical presentation and other findings. "
Patient Sequence No: 1, Text Type: N, H10


[70178706] Falsely elevated or imprecise advia centaur xp vb12 (vitamin b12) results were observed when comparing the results from one advia centaur xp system to another advia centaur xp system, and in some cases elevated compared to an alternate vb 12 test method. Patient treatment was not prescribed or altered. There was no known report of adverse health consequences due to the reported vb12 results.
Patient Sequence No: 1, Text Type: D, B5


[75955355] Siemens filed the initial mdr 1219913-2017-00062 on 03/16/2017 for falsely elevated advia centaur xp vb12 (vitamin b12) results. On (b)(6) 2017 - additional information: a siemens customer service engineer (cse) was sent to the customer site. The cse did not identify any instrument related issues that may have contributed to the advia centaur xp elevated results. The cse changed sample tubes, centrifuge speeds, and proactively performed preventive maintenance (pm). The cause for the elevated advia centaur xp vb12 (vitamin b12) results is unknown. No conclusion can be drawn. The instrument is performing within specifications. No further evaluation of the device is required.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1219913-2017-00062
MDR Report Key6411826
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2017-03-16
Date of Report2017-05-17
Date of Event2017-02-19
Date Mfgr Received2017-04-26
Device Manufacturer Date2016-06-15
Date Added to Maude2017-03-16
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactSTEPHEN PERRY
Manufacturer Street511 BENEDICT AVENUE
Manufacturer CityTARRYTOWN NY 105915097
Manufacturer CountryUS
Manufacturer Postal105915097
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS, INC
Manufacturer Street333 CONEY STREET
Manufacturer CityEAST WALPOLE, MA 02032
Manufacturer CountryUS
Manufacturer Postal Code02032
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameADVIA CENTAUR XP VB12 ASSAY
Generic NameVB12 IMMUNOASSAY,
Product CodeCDD
Date Received2017-03-16
Model NumberN/A
Catalog Number10309970
Lot Number46513231
Device Expiration Date2017-05-15
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Address511 BENEDICT AVENUE TARRYTOWN NY 105915097 US 105915097


Patients

Patient NumberTreatmentOutcomeDate
10 2017-03-16

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.